대한간학회

사회: 조성범 (광주전남지회 총무이사)

10:00-10:05	환영사	홍건영 (광주전남지회 회장)
10:05-10:10	격려사	권영오 (대한간학회 회장)

10:10-11:50	Session 1. The Evolution of Chronic Liver Disease in the Era of Metabolic Syndrome Overload	김윤준 (서울의대), 홍건영 (광주기독병원)
10:10-10:30	Mechanisms of Metabolic Dysfunction and Disease Consequences of MASLD(NAFLD)	손원 (성균관의대)
10:30-10:50	Impact of Metabolic Risk Factors on Prognosis in Patients with Chronic Viral Hepatitis	윤재현 (전남의대)
10:50-11:10	Guidance for Surveillance and Diagnosis of HCC in Patients with MASLD(NAFLD)	곽금연 (성균관의대)
11:10-11:30	Recent Advances in Lean MASLD(NAFLD) and Sarcopenia	유정환 (인하의대)
11:30-11:50	Discussion

11:50-12:50	Lunch

12:50-14:30	Session 2. Management of Patients with Liver Disease and Concurrent Metabolic Disorders	김만우 (조선의대), 권영오 (경북의대)
12:50-13:10	Lifestyle Modifications in Obese and Lean Patients with MASLD(NAFLD): Different Way?	김주영 (바이오뉴트리온)
13:10-13:30	Endocrinologic Practice for Diabetes, Osteoporosis, and Obesity in Chronic Liver Disease	김진화 (조선의대)
13:30-13:50	Cardiovascular Practice for Dyslipidemia, Hypertension, and Atherosclerosis in Chronic Liver Disease	조경훈 (전남의대)
13:50-14:10	Specific Issues and Concerns in the Management of MASLD(NAFLD)-Related HCC	조주연 (조선의대)
14:10-14:30	Discussion

14:30-14:50	Coffee Break

14:50-16:30	Session 3. Present and Future Perspectives on MASLD(NAFLD)	최성규 (전남의대), 장병국 (계명의대)
14:50-15:10	Introduction and Implications of New NAFLD Nomenclatures: MAFLD vs. MASLD	윤아일린 (한양의대)
15:10-15:30	Noninvasive Evaluation of MASLD(NAFLD) and Liver Fibrosis: Clinically Applicable?	이창훈 (전북의대)
15:30-15:50	Molecular Basis and Mechanisms of Progression of MASH(NASH)	한용현 (강원약대)
15:50-16:10	Current and Emerging Pharmacological Options for MASH(NASH) and Obesity	이승원 (가톨릭의대)
16:10-16:30	Discussion

16:30-16:35	경품 추첨 및 폐회사	김윤준 (대한간학회 이사장)

프로그램